Skip to main content
SpringerLink
Log in

What Is the Value of Lymphadenectomy in Early Ovarian Cancer?

  • Chapter
  • First Online:
Controversies in the Management of Gynecological Cancers

  • 1012 Accesses

Abstract

A sizeable proportion of patients with seemingly early-stage ovarian cancer confined to the ovary will have their disease upstaged by lymphadenectomy, and this has obvious prognostic importance. Tumor grade and histology are important when considering this pattern of spread, but the evidence for a survival benefit for lymphadenectomy is scarce, there has been no uniform agreement on the extent of lymphadenectomy, and long-term follow-up of patients who have undergone systematic lymphadenectomy in this context is lacking including quality of life studies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

Part I

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–49.

    Article  PubMed  Google Scholar 

  2. Trimbos B, Timmers P, Pecorelli S, et al. Surgical staging and treatment of early ovarian cancer: long-term analysis from a randomized trial. J Natl Cancer Inst. 2010;102:982–7.

    Article  PubMed Central  PubMed  Google Scholar 

  3. du Bois A, Reuss A, Pujade-Lauraine E, et al. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d’Investigateurs Nationaux Pour les Etudes des Cancers de l’Ovaire (GINECO). Cancer. 2009;115:1234–44.

    Article  PubMed  Google Scholar 

  4. du Bois A, Rochon J, Pfisterer J, et al. Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: a systematic review. Gynecol Oncol. 2009;112:422–36.

    Article  PubMed  Google Scholar 

  5. Kommoss S, Harter P, Traut A, et al. Compliance to consensus recommendations, surgeon’s experience, and introduction of a quality assurance and management program: influence on therapy of early-stage ovarian carcinoma. Int J Gynecol Cancer. 2009;19:787–93.

    Article  PubMed  Google Scholar 

  6. Young RC, Decker DG, Wharton JT, et al. Staging laparotomy in early ovarian cancer. JAMA. 1983;250:3072–6.

    Article  CAS  PubMed  Google Scholar 

  7. Soper JT, Johnson P, Johnson V, et al. Comprehensive restaging laparotomy in women with apparent early ovarian carcinoma. Obstet Gynecol. 1992;80:949–53.

    CAS  PubMed  Google Scholar 

  8. Cass I, Li AJ, Runowicz CD, et al. Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas. Gynecol Oncol. 2001;80:56–61.

    Article  CAS  PubMed  Google Scholar 

  9. Benedetti-Panici P, Greggi S, Maneschi F, et al. Anatomical and pathological study of retroperitoneal nodes in epithelial ovarian cancer. Gynecol Oncol. 1993;51:150–4.

    Article  CAS  PubMed  Google Scholar 

  10. Suzuki M, Ohwada M, Yamada T, et al. Lymph node metastasis in stage I epithelial ovarian cancer. Gynecol Oncol. 2000;79:305–8.

    Article  CAS  PubMed  Google Scholar 

  11. Sakuragi N, Yamada H, Oikawa M, et al. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0). Gynecol Oncol. 2000;79:251–5.

    Article  CAS  PubMed  Google Scholar 

  12. Morice P, Joulie F, Camatte S, et al. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J Am Coll Surg. 2003;197:198–205.

    Article  PubMed  Google Scholar 

  13. Negishi H, Takeda M, Fujimoto T, et al. Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer. Gynecol Oncol. 2004;94:161–6.

    Article  PubMed  Google Scholar 

  14. Takeshima N, Hirai Y, Umayahara K, et al. Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors. Gynecol Oncol. 2005;99:427–31.

    Article  PubMed  Google Scholar 

  15. Maggioni A, Benedetti Panici P, Dell’Anna T, et al. Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer. 2006;95:699–704.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Harter P, Gnauert K, Hils R, et al. Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer. Int J Gynecol Cancer. 2007;17:1238–44.

    Article  CAS  PubMed  Google Scholar 

  17. Burghardt E, Girardi F, Lahousen M, et al. Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer. Gynecol Oncol. 1991;40:103–6.

    Article  CAS  PubMed  Google Scholar 

  18. Baiocchi G, Grosso G, di Re E, et al. Systematic pelvic and paraaortic lymphadenectomy at second-look laparotomy for ovarian cancer. Gynecol Oncol. 1998;69:151–6.

    Article  CAS  PubMed  Google Scholar 

  19. Desteli GA, Gultekin M, Usubutun A, et al. Lymph node metastasis in grossly apparent clinical stage Ia epithelial ovarian cancer: Hacettepe experience and review of literature. World J Surg Oncol. 2010;8:106.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Schmeler KM, Tao X, Frumovitz M, et al. Prevalence of lymph node metastasis in primary mucinous carcinoma of the ovary. Obstet Gynecol. 2010;116:269–73.

    Article  PubMed  Google Scholar 

  21. Rouzier R, Bergzoll C, Brun JL, et al. The role of lymph node resection in ovarian cancer: analysis of the Surveillance, Epidemiology, and End Results (SEER) database. BJOG. 2010;117:1451–8.

    Article  CAS  PubMed  Google Scholar 

  22. Nomura H, Tsuda H, Susumu N, et al. Lymph node metastasis in grossly apparent stages I and II epithelial ovarian cancer. Int J Gynecol Cancer. 2010;20:341–5.

    Article  PubMed  Google Scholar 

  23. Takano M, Sugiyama T, Yaegashi N, et al. The impact of complete surgical staging upon survival in early-stage ovarian clear cell carcinoma: a multi-institutional retrospective study. Int J Gynecol Cancer. 2009;19:1353–7.

    Article  PubMed  Google Scholar 

  24. Fournier M, Stoeckle E, Guyon F, et al. Lymph node involvement in epithelial ovarian cancer: sites and risk factors in a series of 355 patients. Int J Gynecol Cancer. 2009;19:1307–13.

    Article  PubMed  Google Scholar 

  25. Hoskins WJ. Epithelial ovarian carcinoma: principles of primary surgery. Gynecol Oncol. 1994;55:S91–6.

    Article  CAS  PubMed  Google Scholar 

  26. Trimbos JB, Bolis G. Guidelines for surgical staging of ovarian cancer. Obstet Gynecol Surv. 1994;49:814–6.

    Article  CAS  PubMed  Google Scholar 

  27. Powless CA, Aletti GD, Bakkum-Gamez JN, et al. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging. Gynecol Oncol. 2011;122:536–40.

    Article  PubMed  Google Scholar 

  28. Trimbos JB. Lymphadenectomy in ovarian cancer: standard of care or unnecessary risk. Curr Opin Oncol. 2011;23:507–11.

    Article  PubMed  Google Scholar 

  29. du Bois A, Reuss A, Harter P, et al. Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials. J Clin Oncol. 2010;28:1733–9.

    Article  PubMed  Google Scholar 

  30. Trimbos JB, Vergote I, Bolis G, et al. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. J Natl Cancer Inst. 2003;95:113–25.

    Article  CAS  PubMed  Google Scholar 

  31. Zanetta G, Rota S, Chiari S, et al. The accuracy of staging: an important prognostic determinator in stage I ovarian carcinoma. A multivariate analysis. Ann Oncol. 1998;9:1097–101.

    Article  CAS  PubMed  Google Scholar 

  32. Verleye L, Ottevanger PB, van der Graaf W, et al. EORTC-GCG process quality indicators for ovarian cancer surgery. Eur J Cancer. 2009;45:517–26.

    Article  CAS  PubMed  Google Scholar 

  33. Timmers PJ, Zwinderman K, Coens C, et al. Lymph node sampling and taking of blind biopsies are important elements of the surgical staging of early ovarian cancer. Int J Gynecol Cancer. 2010;20:1142–7.

    Article  PubMed  Google Scholar 

  34. Chan JK, Munro EG, Cheung MK, et al. Association of lymphadenectomy and survival in stage I ovarian cancer patients. Obstet Gynecol. 2007;109:12–9.

    Article  PubMed  Google Scholar 

  35. Skirnisdottir I, Sorbe B. Lymph node sampling is of prognostic value in early stage epithelial ovarian carcinoma. Eur J Gynaecol Oncol. 2005;26:181–5.

    CAS  PubMed  Google Scholar 

  36. Carnino F, Fuda G, Ciccone G, et al. Significance of lymph node sampling in epithelial carcinoma of the ovary. Gynecol Oncol. 1997;65:467–72.

    Article  CAS  PubMed  Google Scholar 

  37. Onda T, Yoshikawa H, Yokota H, et al. Assessment of metastases to aortic and pelvic lymph nodes in epithelial ovarian carcinoma. A proposal for essential sites for lymph node biopsy. Cancer. 1996;78:803–8.

    Article  CAS  PubMed  Google Scholar 

Part II

  1. Calcagno M, Montera R, Cafa EV, Sereni MI, Panici PB, Angioli R, Plotti F, Palaia I. Update on lymphadenectomy in early and advanced ovarian cancer. Curr Opin Obstet Gynecol. 2008;20(1):34–9. Review.

    Article  PubMed  Google Scholar 

  2. Rungruang B, Miller A, Richard SD, Hamilton CA, Rodriguez N, Bookman MA, Maxwell GL, Horowitz NS. Should stage IIIC ovarian cancer be further stratified by intraperitoneal vs. retroperitoneal only disease? A Gynecologic Oncology Group study. Gynecol Oncol. 2012;124(1):53–8. Epub 2011 Oct 26.

    Article  PubMed  Google Scholar 

  3. Benedetti-Panici P, Maggioni A, Hacker N, Landoni F, Ackermann S, Campagnutta E, et al. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst. 2005;97:560–6.

    Article  Google Scholar 

  4. Scarabelli C, Gallo A, Zarrelli A, Visentin C, Campagnutta E. Systematic pelvic and para-aortic lymphadenectomy during cytoreductive surgery in advanced ovarian cancer: potential benefit on survival. Gynecol Oncol. 1995;56(3):328–37.

    Article  CAS  PubMed  Google Scholar 

  5. Maggioni A, Benedetti Panici P, Dell’Anna T, Landoni F, Lissoni A, Pellegrino A, et al. Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer. 2006;18:699–704.

    Article  Google Scholar 

  6. International Collaborative Ovarian Neoplasm (ICON1) Collaborators. International collaborative ovarian neoplasm trial 1 and adjuvant chemotherapy in ovarian neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J Natl Cancer Inst. 2003;95:105–12.

    Article  Google Scholar 

  7. Kleppe M, Wang T, Van Gorp T, Slangen BF, Kruse AJ, Kruitwagen RF. Lymph node metastasis in stages I and II ovarian cancer: a review. Gynecol Oncol. 2011;123(3):610–4. Epub 2011 Oct 6. Review.

    Article  CAS  PubMed  Google Scholar 

  8. Satoh T, Hatae M, Watanabe Y, Yaegashi N, Ishiko O, Kodama S, et al. Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection. Clin Oncol. 2010;28(10):1727–32. Epub 2010 Mar 1. Erratum in: J Clin Oncol. 2011;29(35):4725.

    Article  Google Scholar 

  9. Uzan C, Morice P, Rey A, et al. Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrences exclusively in lymph nodes. Ann Surg Oncol. 2004;11:658–64.

    Article  PubMed  Google Scholar 

  10. Benedetti Panici P, Perniola G, Angioli R, et al. Bulky lymph node resection in patients with recurrent epithelial ovarian cancer: impact of surgery. Int J Gynecol Cancer. 2007;17:1245–51.

    Article  CAS  PubMed  Google Scholar 

  11. Bell J, Brady MF, Young RC, Lage J, Walker JL, Look KY, Rose GS, Spirtos NM, Gynecologic Oncology Group. Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2006;102(3):432.

    Article  CAS  PubMed  Google Scholar 

  12. Chan JK, Tian C, Fleming GF, Monk BJ, Herzog TJ, Kapp DS, Bell J. The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group study. Gynecol Oncol. 2010;116(3):301.

    Article  PubMed  Google Scholar 

  13. Young RC, Walton LA, Ellenberg SS, Homesley HD, Wilbanks GD, Decker DG, Miller A, Park R, Major Jr F. Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials. N Engl J Med. 1990;322(15):1021.

    Article  CAS  PubMed  Google Scholar 

  14. Kim HS, Ju W, Jee BC, Kim YB, Park NH, Song YS, Kim SC, Kang SB, Kim JW. Systematic lymphadenectomy for survival in epithelial ovarian cancer: a meta-analysis. Int J Gynecol Cancer. 2010;20(4):520–8.

    Article  PubMed  Google Scholar 

  15. Berek JS. Lymph node-positive stage IIIC ovarian cancer: a separate entity? Int J Gynecol Cancer. 2009;19 Suppl 2:S18–20. Review.

    Article  PubMed  Google Scholar 

  16. Dizon DS, Restivo A, Lomme M, Charbonneau N, Brard L, Hughes T, Weitzen S, Legare R, Granai CO, Disilvestro P. For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging? Am J Clin Oncol. 2008;31(1):39–42.

    Article  PubMed  Google Scholar 

  17. Ayhan A, Celik H, Dursun P. Lymphatic mapping and sentinel node biopsy in gynecological cancers: a critical review of the literature. World J Surg Oncol. 2008;6:53.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Nyberg RH, Korkola P, Mäenpää J. Ovarian sentinel node: is it feasible? Int J Gynecol Cancer. 2011;21(3):568–72.

    Article  PubMed  Google Scholar 

  19. Colomer AT, Jiménez AM, Bover Barceló MI. Laparoscopic treatment and staging of early ovarian cancer. J Minim Invasive Gynecol. 2008;15(4):414–9. Epub 2008 Jun 6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, Hamburg, 20246, Germany

    Sven Mahner MD

  2. Gynecologic Cancer Center, Herzog-Friedrich-Str. 21, Kiel, 24106, Germany

    Jacobus Pfisterer MD

  3. Gynaecology Oncology, King Edward Memorial Hospital, 374 Bagot Road, Perth, WA, 6008, Australia

    Ganendra Raj K. Ali Mohan MBBS, MRCOG, FRANZCOG, CGO

  4. The University of Melbourne, Royal Women’s Hospital, Melbourne, Australia

    Michael A. Quinn MB, ChB, MGO (Melb), MRCP (UK), FRANZCOG, FRCOG, CGO (Professor of Gynaecological Oncology)

Authors
  1. Sven Mahner MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jacobus Pfisterer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ganendra Raj K. Ali Mohan MBBS, MRCOG, FRANZCOG, CGO
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael A. Quinn MB, ChB, MGO (Melb), MRCP (UK), FRANZCOG, FRCOG, CGO
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Sven Mahner MD , Sven Mahner MD or Ganendra Raj K. Ali Mohan MBBS, MRCOG, FRANZCOG, CGO .

Editor information

Editors and Affiliations

  1. UCL Cancer Institute, University College London, London, United Kingdom

    Jonathan A. Ledermann

  2. Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands

    Carien L. Creutzberg

  3. Royal Women’s Hospital, The University of Melbourne, Melbourne, Australia

    Michael A. Quinn

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Mahner, S., Pfisterer, J., Mohan, G.R.K.A., Quinn, M.A. (2014). What Is the Value of Lymphadenectomy in Early Ovarian Cancer?. In: Ledermann, J., Creutzberg, C., Quinn, M. (eds) Controversies in the Management of Gynecological Cancers. Springer, London. https://doi.org/10.1007/978-0-85729-910-9_16

Download citation

  • DOI: https://doi.org/10.1007/978-0-85729-910-9_16

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-909-3

  • Online ISBN: 978-0-85729-910-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation